Idera Pharmaceuticals, Inc. [IDRA]

Source: 

Company Overview

Aceragen, Inc is a clinical-stage biopharmaceutical company with a business strategy focused on the clinical development, and ultimately the commercialization, of drug candidates for rare disease indications characterized by small, well-defined patient populations with serious unmet medical needs.